Prevagen’s most commonly reported side effect is headache, followed by dizziness and nausea. While the supplement is marketed as a memory-boosting pill, a review of over 2,000 adverse event reports paints a more complicated safety picture than its advertising suggests.
Most Common Side Effects
Two physicians hired by Prevagen’s manufacturer, Quincy Bioscience, reviewed 2,281 adverse events reported by consumers. The most frequently reported problem was headache, occurring in nearly 19% of reports. Dizziness accounted for about 7.5%, nausea for roughly 7%, and high blood pressure for about 3.7%. These numbers come from the company’s own data, submitted as part of a safety filing that was later withdrawn.
For most people, these side effects are mild and resolve on their own. But the pattern is worth noting: nearly one in five adverse event reports involved headaches, which is a high rate for a supplement that contains a single protein as its active ingredient.
More Serious Reported Reactions
The FDA has flagged a more troubling set of adverse events. According to the agency, Quincy Bioscience failed to disclose over a thousand reported adverse reactions. These included seizures, strokes, chest pains, tremors, fainting, and worsening symptoms of multiple sclerosis. Perhaps most ironic for a product sold to improve memory: some users reported memory impairment and confusion.
It’s important to put this in context. Adverse event reports don’t prove the supplement caused these problems. Many Prevagen users are older adults who may have underlying health conditions. But the sheer volume of undisclosed reports, and the severity of some of them, raised enough concern for federal regulators to act.
Allergic Reactions
Prevagen’s active ingredient, apoaequorin, is a protein originally derived from jellyfish (now made synthetically in a lab). Any protein has the theoretical potential to trigger an allergic response. If you have a known allergy to jellyfish or shellfish, this is worth keeping in mind, though the actual allergy risk appears low. Studies show that 90% of apoaequorin breaks down in the digestive tract in less than 30 seconds, leaving very little intact protein to provoke an immune reaction.
Drug Interactions
The honest answer here is that nobody really knows. The risk for serious drug interactions with apoaequorin has not been established. Because Prevagen is sold as a dietary supplement rather than a drug, it hasn’t undergone the rigorous interaction testing that prescription medications require. If you take blood thinners, blood pressure medications, or other daily prescriptions, the absence of interaction data isn’t the same as a guarantee of safety.
What Happens to Prevagen in Your Body
Understanding how the body handles apoaequorin helps explain both its side effect profile and the broader controversy around the product. Apoaequorin is a protein made up of 196 amino acids. When you swallow it, your stomach acid and digestive enzymes tear it apart almost immediately. Lab simulations found that 90% of the protein is destroyed within 30 seconds of hitting stomach acid.
This raises an obvious question: if the protein is digested before it can reach the bloodstream, how could it improve brain function? Even if a small fraction survived digestion, scientists consider it highly unlikely that a protein this large could cross the blood-brain barrier. This is the central problem with Prevagen’s marketing claims, and it’s the reason regulators stepped in.
The FTC Case Against Prevagen
In December 2024, the Federal Trade Commission won a lawsuit against Quincy Bioscience after seven years of litigation, including a jury trial. The court ordered the company to stop making deceptive claims about Prevagen’s ability to improve memory. The FTC’s position was straightforward: health claims need to be backed by reliable scientific evidence, and Prevagen’s were not.
This matters for the side effects conversation because it reframes the risk-benefit equation. If the benefit side of the ledger is essentially empty, as federal regulators concluded, then even mild side effects like headaches and dizziness carry more weight. You’re accepting the risk of adverse effects from a product that hasn’t demonstrated it does what it promises.
Dosage and Safety Thresholds
Prevagen comes in Regular Strength (10 mg) and Extra Strength (20 mg) as a once-daily capsule or chewable tablet. A 40 mg version also exists. Animal studies found no toxic effects at doses 4,000 to 16,000 times the regular strength amount, which suggests the protein itself has a wide safety margin in terms of acute toxicity.
But animal toxicity studies test for poisoning, not for the subtler adverse effects that consumers actually report. A substance can be non-toxic in the traditional sense while still causing headaches, dizziness, or nausea in a meaningful percentage of users. The animal data tells you Prevagen probably won’t cause organ damage. It doesn’t tell you whether you’ll feel good taking it.